Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAxis Bank 144a Regulatory News (AXBA)

Share Price Information for Axis Bank 144a (AXBA)

Share Price is delayed by 15 minutes
Get Live Data
40.9145    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $25.45b
AXBA Live PriceLast checked at - London Stock Exchange

Intraday Axis Bank 144a Share Chart

ESOP Grant

16 Jul 2025 09:38

RNS Number : 2977R
Axis Bank Limited
16 July 2025
 

AXIS/CO/CS/171/2025-26

 

July 16, 2025

 

National Stock Exchange of India Limited

Exchange Plaza, 5th Floor

Plot No. C/1, "G" Block

Bandra-Kurla Complex

Bandra (E), Mumbai - 400 051

 

NSE Symbol: AXISBANK

BSE Limited

1st Floor,

P. J. Towers,

Dalal Street

Fort, Mumbai - 400 001

 

BSE Scrip Code: 532215

 

Dear Sir/Madam,

 

REF.:

DISCLOSURE UNDER REGULATION 30 OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015

SUB.:

GRANT OF STOCK OPTIONS/UNITS

 

This is to inform you that the Nomination and Remuneration Committee at its meeting held today i.e., July 16, 2025, has granted 1,37,575 stock options at an exercise price of Rs. 1,165.90/- per option under the Axis Bank Employees Stock Option Scheme 2000-01 to the eligible employees of the Bank.

 

Disclosures as required under SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, is enclosed as Annexure A.

 

The meeting commenced at 10.30 am (IST) and concluded at 1:40 pm (IST).

 

This is for your information and records.

 

Yours faithfully,

 

For Axis Bank Limited

 

 

Sandeep Poddar

Company Secretary

CC: 

London Stock Exchange

Singapore Stock Exchange

 

 

 

Annexure A

 

Sr. No.

Particulars

Grant under Axis Bank Employees Stock Option Scheme 2000-01

(a)

Brief details of options/units granted

1,37,575 options.

(b)

Whether the scheme is in terms of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021

Yes

(c)

Total number of shares covered by these options/units

1,37,575 equity shares of Rs. 2/- each of the Bank.

(d)

Pricing Formula

Granted at the latest available closing price prevailing on NSE being the Stock Exchange which recorded the highest trading volume in the equity shares of the Bank on July 15, 2025 i.e., being the previous trading day immediately preceding the date on which the grant of options was approved by the NRC.

(e)

Option Vested

The said options shall vest, as under:

- At the end of 1 year from the date of grant - 30% of granted options.

- At the end of 2 years from the date of grant - 30% of granted options.

- At the end of 3 years from the date of grant - 40% of granted options

(f)

Time within which option/units may be exercised

The said options can be exercised by the grantees, within a period of 5 years from the date of respective vesting.

 

 http://www.rns-pdf.londonstockexchange.com/rns/2977R_1-2025-7-16.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSFISAMEISEDW
Date   Source Headline
26th Oct 202312:56 pmRNSAppointment of Whole Time Director
25th Oct 202312:40 pmRNSRelated Party Transaction
25th Oct 202312:18 pmRNSInvestor Presentation and Press Release
25th Oct 202312:02 pmRNSOutcome of Board Meeting 25102023
17th Oct 202310:00 amRNSCredit Rating
6th Oct 20231:25 pmRNSBoard Meeting Intimation 25102023
3rd Oct 20233:00 pmRNSCredit Rating
26th Sep 202312:46 pmRNSPostal Ballot Notice
13th Sep 202310:07 amRNSDisclosure under Reg 30 of SEBI (LODR) Reg. 2015
17th Aug 20234:46 pmRNSRBI Approval for appointment of Subrat Mohanty
9th Aug 20231:45 pmRNSDisclosure under Reg 30 of SEBI (LODR) Regulations
9th Aug 202312:36 pmRNSDisclosure Under Reg 30 of SEBI (LODR) Reg, 2015
1st Aug 20234:58 pmRNSResignation of Independent Director
27th Jul 20231:54 pmRNSOutcome of Board meeting
27th Jul 202310:47 amRNSAppointment
26th Jul 202312:50 pmRNSInvestor Presentation and Press Release
26th Jul 202312:44 pmRNSOutcome of Board Meeting 26072023
17th Jul 20235:23 pmRNSReclassification of Promoter
27th Jun 20234:12 pmRNSCredit Rating
26th Jun 202312:09 pmRNSNotice of Annual General Meeting and Annual Report
16th Jun 20231:53 pmRNSAppointment of Non-Executive (Part-time) Chairman
30th May 20233:44 pmRNSIntimation of Record date for Dividend
30th May 20233:30 pmRNSAppointment of Additional Independent Director
4th May 20231:49 pmRNSReclassification of Promoter
28th Apr 20233:39 pmRNSAmendment to Articles of Association
28th Apr 20233:25 pmRNSReclassification of Promoter
28th Apr 20233:20 pmRNSResults of Postal Ballot
28th Apr 202311:18 amRNSAppointment of Whole Time Director
27th Apr 202312:44 pmRNSBoard Meeting Outcome - Dividend and Fund Raising
24th Apr 20237:00 amRNSDisclosure under Reg 30 of SEBI (LODR) Reg. 2015
29th Mar 20232:49 pmRNSPostal Ballot Notice
27th Mar 20233:47 pmRNSDisclosure under Reg. 30 of SEBI (LODR) Reg. 2015
14th Mar 20231:12 pmRNSRating Action by CRISIL RATINGS LIMITED
13th Mar 20231:56 pmRNSCredit Rating
23rd Feb 20233:17 pmRNSUpdate on acquisition of business undertakings
10th Feb 20231:27 pmRNSCessation of Independent Director
6th Feb 20237:00 amRNSClarification - Bank’s exposure to Adani Group
24th Jan 20237:00 amRNSRevised Press Release and Investor Presentation
11th Jan 20237:00 amRNSBoard Meeting Intimation
13th Dec 202211:44 amRNSAllotment of NCD
7th Dec 20222:49 pmRNSRating Action by ICRA Ratings Limited
7th Dec 20221:55 pmRNSDisclosure under Regulation 30 of SEBI (LODR) Reg
21st Oct 20222:57 pmRNSRATING ACTION BY FITCH RATINGS
21st Oct 202211:40 amRNSRe-appointment of Chief Risk Officer
20th Oct 20222:24 pmRNSAppointment of Additional Independent Director
20th Oct 202212:49 pmRNSOutcome of Board Meeting - October 20, 2022
4th Aug 20223:46 pmRNSUpdate on Sale of Axis Bank UK Limited
2nd Aug 202212:08 pmRNSRegulation 30 - Disclosure of SEBI(LODR) Reg, 2015
29th Jul 20221:53 pmRNSOutcome of Annual General Meeting - July 29, 2022
26th Jul 20222:35 pmRNSApproval of Competition Commission of India

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.